| |
 |
|
|
|
|
|
|
|
|
-
Florida Drug Treatment Center to Offer Cutting Edge Neurotransmitter Testing
The Ambrosia Treatment Centers, who have locations in both Singer Island and Port St. Lucie, on Florida's Southeast coast, have announced the availability of neurotransmitter testing for their clients. This cutting edge testing will help clients in their recovery from alcoholism, addiction and related mental disorders.
Read more ...
-
Migraine Research Foundation Announces Winners of 2009 Research Grants
The Migraine Research Foundation today announced the winners of the 2009 research grants. This year's grantees will explore such important areas as pediatric migraine, the genetic association between migraine and cardiovascular events, and why opioids enhance migraine pain.
Read more ...
-
Nutra Pharmaceutical's U.S. distributor, XenaCare Holdings Announces National Print Advertising Campaign for Cobroxin, a Treatment for Moderate to Severe (Stage 2) Pain
Nutra Pharmaceutical's U.S. distributor, XenaCare Holdings announced that its national print advertising campaign for Cobroxin, the first clinically proven, over-the-counter treatment for moderate to severe (stage 2) chronic pain, is scheduled to begin in November and will run in Arthritis Today, Prevention, Health, Star, Woman's World, Soap Opera, and Self Magazines.
Read more ...
-
PAINWeek 2009 Welcomes Over 1,000 Attendees
PAINWeek 2009 is a national conference that takes place during September -- Pain Awareness Month. The meeting provides knowledge and tools for frontline practitioners who treat patients in pain. The conference will convene at the Red Rock Casino, Resort and Spa in Las Vegas, September 9-12, 2009 and offers over 100 CE/CME hours during the 4-day conference.
Read more ...
-
Impact Medical Solutions, Inc. (dba iTech Medical) Engages D&D Securities Company
Impact Medical Solutions, Inc. (dba iTech Medical) (OTCBB: IMSU) announces engagement of D&D Securities as investment banker. Keywords: healthcare, biomedical, back pain, neck pain, muscle pattern recognition, medical device, wellness.
Read more ...
-
Spinal Implant Developed by Sanford Clinic Neurosurgeon Receives FDA 510(k) Market Clearance as a Lumbar Intervertebral Body Fusion Device
Sanford Health, a comprehensive health care provider in the Upper Midwest, announced today a spinal implant developed by Sanford Clinic Neurosurgeon, Wilson Asfora, MD, Sanford Clinic Neurosurgery & Spine, has received United States Food and Drug Administration (FDA) 510(k) market clearance as a lumbar intervertebral body fusion device.
Read more ...
-
Stemedica Selected By World Stem Cell Summit To Present Scientific Discoveries
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing (a licensed manufacturer of clinical grade biological products as licensed by the State of California Food and Drug Branch) continues to advance the stem cell industry with the presentation of two of its latest scientific discoveries at the 2009 World Stem Cell Summit.
Read more ...
-
Fast Forward, LLC and Amplimmune, Inc. Join Forces to Speed New Treatments to People with MS**
Companies Announce a Collaboration for the Development of AMP-110 - An Innovative Treatment for Multiple Sclerosis and Other Autoimmune Diseases
Read more ...
-
The Nation's Leading Provider of Medical Transcription Services to Physician Practices, MxSecure, Inc., Named to Inc. 5000 Fastest Growing Private Companies in America
MxSecure, the nation's leading provider of medical transcription services and clinical documentation software to solo practitioners, physician practices and community health centers, announced that they have been named to the 2009 Inc. 5000 list of the fastest growing private companies in America. This is the second consecutive year MxSecure has made the Inc. 5000 list.
Read more ...
-
UAB Health System Opts for Posey Beds
University hospital uses enclosed beds for improved patient safety and comfort;brain and head injury unit cites impact on fall reduction.
Read more ...
 |
|
 |
|
|
|
|
|
